Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation

Clinical trial NCT05321498 · WITHDRAWN

Trial details

NCT number: NCT05321498
Sponsor: Inmune Bio, Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Mild Cognitive Impairment (MCI)Alzheimer Disease Dementia Brain Diseases Central Nervous System Diseases Nervous System Diseases Tauopathies Neurodegenerative Diseases Mental Disorders

Start date: 2023-06-01
Primary completion: 2023-10-26
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.